Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma, Published online: 09 January 2018; doi:10.1038/bjc.2017.469

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

http://ift.tt/2FicbCh